相关实验视频
Updated: Jun 11, 2025
06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
444
在阿尔茨海默病的非药理学炼随机对照试验
Nizhuan Wang1, Hsu-Chih Tai2, I-Shiang Tzeng3
1Department of Chinese and Bilingual Studies, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Journal of Alzheimer's disease : JAD
|September 27, 2024
概括
定期炼可以改善认知功能,并减少阿尔茨海默病 (AD) 中的神经心理症状. 身体活动是关键的可修改风险因素,提供了比药物更少的副作用的好处.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 运动生理学 运动生理学
背景情况:
- 阿尔茨海默病 (AD) 构成了全球重大健康挑战.
- 身体不活动是AD发展的普遍可修改的风险因素.
- 神经精神症状和认知能力下降是阿尔茨海默病的标志.
研究的目的:
- 审查关于在临床前阿尔茨海默病中运动反应的证据.
- 总结长期运动对AD认知表现和神经精神症状的影响.
- 识别知识缺口,并为未来的研究提供建议.
主要方法:
- 现有研究对AD的运动干预措施的叙述性综述.
- 关于运动对认知功能和神经精神症状的影响的综合证据.
- 专家主导的总结和研究障碍的识别.
主要成果:
- 长期的运动疗法可以增强大脑血流,增加海马体积,并促进神经发生.
- 较高的体力活动水平与患AD的风险降低有关.
- 运动对阿尔茨海默病患者的认知功能和神经精神症状有好处,比药物治疗更好地坚持治疗,副作用更少.
结论:
- 运动是一种有前途的非药物干预措施,用于管理AD症状.
- 需要进一步的研究来优化练习协议,并解决实施障碍.
- 为设计未来的运动和AD随机试验提供了建议.
相关概念视频
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:26Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451